Related Experiment Video
Updated: May 28, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Runx2/Smad3 complex negatively regulates TGF-β-induced connective tissue growth factor gene expression in vascular
Yoshiaki Ohyama1, Toru Tanaka, Takehisa Shimizu
1Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Aim:
Connective tissue growth factor (CTGF), a direct target gene of transforming growth factor-β (TGF-β) signaling, plays an important role in the development of atherosclerosis. We previously showed that Runx2, a key transcription factor in osteoblast differentiation, regulates osteogenic conversion and dedifferentiation of vascular smooth muscle cells (VSMCs). In this study, we investigated the hypothesis that Runx2 modulates CTGF gene expression via the regulation of TGF-β signaling.
Methods And Results:
Expression of the Runx2 gene was decreased, and CTGF mRNA levels were reciprocally increased by TGF-β in a time-dependent manner in cultured human aortic smooth muscle cells (HASMCs) and C3H10T1/2 cells. Forced expression of Runx2 decreased and the reduction of Runx2 expression by small interfering RNA enhanced both basal and TGF-β-stimulated CTGF gene expression in HASMCs. Site-directed mutation analysis of the CTGF promoter indicated that transcriptional repression by Runx2 was mediated by the Smad-binding element (SBE) under basal and TGF-β-stimulated conditions. Data obtained from immunoblots of Runx2-, Smad3- or Smad4-transfected cells and chromatin immunoprecipitation analysis indicated that Runx2 interacts with Smad3 at the SBE. Immunohistochemistry revealed that the expression of Runx2 and CTGF was distinct and almost mutually exclusive in human atherosclerotic plaque.
Conclusions:
These results for the first time demonstrate that Runx2/Smad3 complex negatively regulates endogenous and TGF-β-induced CTGF gene expression in VSMCs. Thus, the induction of Runx2 expression contributes to the phenotypic modulation of VSMCs, in which the TGF-β/Smad pathway plays a major role.
Insights
Runx2, a transcription factor, negatively regulates connective tissue growth factor (CTGF) gene expression in vascular smooth muscle cells (VSMCs) by interacting with Smad3. This finding clarifies the role of Runx2 in atherosclerosis development.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Cell Biology
Background:
- Connective tissue growth factor (CTGF) is implicated in atherosclerosis development and is a target of transforming growth factor-β (TGF-β) signaling.
- Runx2, a transcription factor crucial for osteoblast differentiation, influences vascular smooth muscle cell (VSMC) phenotype.
- Previous work demonstrated Runx2's role in VSMC osteogenic conversion and dedifferentiation.
Purpose of the Study:
- To investigate if Runx2 modulates CTGF gene expression through TGF-β signaling.
- To elucidate the molecular mechanisms underlying Runx2's regulation of CTGF.
Main Methods:
- Cultured human aortic smooth muscle cells (HASMCs) and C3H10T1/2 cells were used to study gene expression.
- TGF-β treatment was applied to assess its effect on Runx2 and CTGF levels.
- Runx2 expression was manipulated using forced expression and small interfering RNA (siRNA).
- CTGF promoter analysis, site-directed mutagenesis, immunoblots, and chromatin immunoprecipitation (ChIP) were employed.
- Immunohistochemistry was used to examine Runx2 and CTGF expression in human atherosclerotic plaques.
Main Results:
- TGF-β decreased Runx2 expression while increasing CTGF mRNA levels in HASMCs and C3H10T1/2 cells.
- Overexpression of Runx2 reduced CTGF expression, whereas Runx2 knockdown enhanced it.
- Runx2 repressed CTGF promoter activity via the Smad-binding element (SBE).
- Runx2 physically interacted with Smad3 at the SBE.
- Runx2 and CTGF expression patterns were mutually exclusive in human atherosclerotic lesions.
Conclusions:
- Runx2, in complex with Smad3, acts as a negative regulator of CTGF gene expression in VSMCs.
- This Runx2/Smad3 complex inhibits both basal and TGF-β-induced CTGF expression.
- Runx2 induction contributes to VSMC phenotypic modulation within the context of TGF-β/Smad signaling.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Hedgehog Signaling Pathway
Master Transcription Regulators

